help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruan, W.
Right arrow Articles by Kleinberg, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruan, W.
Right arrow Articles by Kleinberg, D. L.
Endocrinology Vol. 140, No. 11 5075-5081
Copyright © 1999 by The Endocrine Society

ARTICLES

Insulin-Like Growth Factor I Is Essential for Terminal End Bud Formation and Ductal Morphogenesis during Mammary Development1

Weifeng Ruan and David L. Kleinberg

Departments of Medicine, New York University School of Medicine, and Department of Veterans Affairs Medical Center, New York, New York 10010

Address all correspondence and requests for reprints to: David L. Kleinberg, M.D., New York School of Medicine, Room 16043W, 423 East 23rd Street, New York, New York 10010. E-mail: kleind02{at}popmail.med.nyu.edu

Previous studies from this laboratory have emphasized the essential role of GH in pubertal mammary development and shown that insulin-like growth factor I (IGF-I) was capable of substituting for GH in this process in rats and mice. The present study shows that, even when GH is present, no mammary development is possible unless IGF-I is present. IGF-I(-/-) null female animals were found to have significantly less mammary development than age matched wild-type controls (P <0.006) using several endpoints including the number of terminal end buds or TEBs (1.3 vs. 7.3), percent of the fat pad occupied by glandular elements (6.5 vs. 100), and number of ducts (15 vs. too numerous to count). That the deficiency in mammary gland development was related to the absence of IGF-I was underscored by the observation that des (1–3) IGF-I administration to IGF-I(-/-) null animals for 5 days caused significant mammary gland development as measured by TEB formation and branching of ducts. The number of TEBs rose from a mean of 1.3 in controls to 20.5 without added E2 (P < 0.009), and from 1.7 to 21 when des (1–3) IGF-I was given together with E2 (P < 0.006). The number of ducts increased significantly from a mean of 12 to 27 in response to IGF-I and E2, and from 15 to 24.5 with IGF-I alone. In contrast, administration of human GH with E2 had no stimulatory effect on mammary development in these animals, indicating that the full effect of GH in this process is mediated by IGF-I.

To determine whether IGF-I was also responsible for further ductal morphogenesis, we administered des (1–3) IGF-I + E2 to the knockout animals for 14 days and compared the effects of this combination of hormones on mammary development with those observed after 5 days. We found that there was a significant increase from 5 to 14 days in the number of TEBs (mean: 21 vs. 41) and the area of the mammary fat pad occupied by glands (mean: 10 vs. 20%). There was elongation and thickening of the ducts which accounted for the increased area that was occupied by ductal structures. There was no significant increase in the number of ducts. However, there was the appearance of a large number of buds along the length of the ductal structures, suggesting the beginning of side branching. These results suggest that IGF-I, when given along with E2, is responsible for ductal morphogenesis.




This article has been cited by other articles:


Home page
 J EndocrinolHome page
S. R Thorn, S. Purup, M. Vestergaard, K. Sejrsen, M. J Meyer, M. E Van Amburgh, and Y. R Boisclair
Regulation of mammary parenchymal growth by the fat pad in prepubertal dairy heifers: role of inflammation-related proteins
J. Endocrinol., March 1, 2008; 196(3): 539 - 546.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M J Meyer, R P Rhoads, A V Capuco, E E Connor, A Hummel, Y R Boisclair, and M E Van Amburgh
Ontogenic and nutritional regulation of steroid receptor and IGF-I transcript abundance in the prepubertal heifer mammary gland
J. Endocrinol., October 1, 2007; 195(1): 59 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. N. Lucas, D. G. Rudmann, K. M. Credille, A. R. Irizarry, A. Peter, and P. W. Snyder
The Rat Mammary Gland: Morphologic Changes as an Indicator of Systemic Hormonal Perturbations Induced by Xenobiotics
Toxicol Pathol, February 1, 2007; 35(2): 199 - 207.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. V. Loladze, M. A. Stull, A. M. Rowzee, J. DeMarco, J. H. Lantry III, C. J. Rosen, D. LeRoith, K.-U. Wagner, L. Hennighausen, and T. L. Wood
Epithelial-Specific and Stage-Specific Functions of Insulin-Like Growth Factor-I during Postnatal Mammary Development
Endocrinology, November 1, 2006; 147(11): 5412 - 5423.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M J Meyer, A V Capuco, Y R Boisclair, and M E Van Amburgh
Estrogen-dependent responses of the mammary fat pad in prepubertal dairy heifers.
J. Endocrinol., September 1, 2006; 190(3): 819 - 827.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
X.-J. Wang, E. Bartolucci-Page, S. E. Fenton, and L. You
Altered Mammary Gland Development in Male Rats Exposed to Genistein and Methoxychlor
Toxicol. Sci., May 1, 2006; 91(1): 93 - 103.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Mukhina, D. Liu, K. Guo, M. Raccurt, S. Borges-Bendris, H. C. Mertani, and P. E. Lobie
Autocrine Growth Hormone Prevents Lactogenic Differentiation of Mouse Mammary Epithelial Cells
Endocrinology, April 1, 2006; 147(4): 1819 - 1829.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
W. Ruan, F. Fahlbusch, D. R. Clemmons, M. E. Monaco, P. D. Walden, A. P. Silva, H. A. Schmid, and D. L. Kleinberg
SOM230 Inhibits Insulin-Like Growth Factor-I Action in Mammary Gland Development by Pituitary Independent Mechanism: Mediated through Somatostatin Subtype Receptor 3?
Mol. Endocrinol., February 1, 2006; 20(2): 426 - 436.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
P. W. Parodi
Dairy Product Consumption and the Risk of Breast Cancer
J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 556S - 568S.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
J M Fleming, B J Leibowitz, D E Kerr, and W S Cohick
IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells
J. Endocrinol., July 1, 2005; 186(1): 165 - 178.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. Ruan, M. E. Monaco, and D. L. Kleinberg
Progesterone Stimulates Mammary Gland Ductal Morphogenesis by Synergizing with and Enhancing Insulin-Like Growth Factor-I Action
Endocrinology, March 1, 2005; 146(3): 1170 - 1178.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. J. Jackson-Fisher, G. Bellinger, R. Ramabhadran, J. K. Morris, K.-F. Lee, and D. F. Stern
ErbB2 is required for ductal morphogenesis of the mammary gland
PNAS, December 7, 2004; 101(49): 17138 - 17143.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. G. Richards, D. M. Klotz, M. P. Walker, and R. P. DiAugustine
Mammary Gland Branching Morphogenesis Is Diminished in Mice with a Deficiency of Insulin-like Growth Factor-I (IGF-I), But Not in Mice with a Liver-Specific Deletion of IGF-I
Endocrinology, July 1, 2004; 145(7): 3106 - 3110.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. V. Lee, P. Zhang, M. Ivanova, S. Bonnette, S. Oesterreich, J. M. Rosen, S. Grimm, R. C. Hovey, B. K. Vonderhaar, C. R. Kahn, et al.
Developmental and Hormonal Signals Dramatically Alter the Localization and Abundance of Insulin Receptor Substrate Proteins in the Mammary Gland
Endocrinology, June 1, 2003; 144(6): 2683 - 2694.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
X. Cui, P. Zhang, W. Deng, S. Oesterreich, Y. Lu, G. B. Mills, and A. V. Lee
Insulin-Like Growth Factor-I Inhibits Progesterone Receptor Expression in Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway: Progesterone Receptor as a Potential Indicator of Growth Factor Activity in Breast Cancer
Mol. Endocrinol., April 1, 2003; 17(4): 575 - 588.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. J. Allan, E. Tonner, M. C. Barber, M. T. Travers, J. H. Shand, R. G. Vernon, P. A. Kelly, N. Binart, and D. J. Flint
Growth Hormone, Acting in Part through the Insulin-Like Growth Factor Axis, Rescues Developmental, But Not Metabolic, Activity in the Mammary Gland of Mice Expressing a Single Allele of the Prolactin Receptor
Endocrinology, November 1, 2002; 143(11): 4310 - 4319.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. A. Stull, M. M. Richert, A. V. Loladze, and T. L. Wood
Requirement for IGF-I in Epidermal Growth Factor-Mediated Cell Cycle Progression of Mammary Epithelial Cells
Endocrinology, May 1, 2002; 143(5): 1872 - 1879.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
L. You, M. Sar, E. J. Bartolucci, B. S. McIntyre, and R. Sriperumbudur
Modulation of Mammary Gland Development in Prepubertal Male Rats Exposed to Genistein and Methoxychlor
Toxicol. Sci., April 1, 2002; 66(2): 216 - 225.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. M. Shillingford, K. Miyoshi, G. W. Robinson, S. L. Grimm, J. M. Rosen, H. Neubauer, K. Pfeffer, and L. Hennighausen
Jak2 Is an Essential Tyrosine Kinase Involved in Pregnancy-Mediated Development of Mammary Secretory Epithelium
Mol. Endocrinol., March 1, 2002; 16(3): 563 - 570.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. G. Bonnette and D. L. Hadsell
Targeted Disruption of the IGF-I Receptor Gene Decreases Cellular Proliferation in Mammary Terminal End Buds
Endocrinology, November 1, 2001; 142(11): 4937 - 4945.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Oesterreich, P. Zhang, R. L. Guler, X. Sun, E. M. Curran, W. V. Welshons, C. K. Osborne, and A. V. Lee
Re-expression of Estrogen Receptor {alpha} in Estrogen Receptor {alpha}-negative MCF-7 Cells Restores both Estrogen and Insulin-like Growth Factor-mediated Signaling and Growth
Cancer Res., August 1, 2001; 61(15): 5771 - 5777.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. W. Chan, M. Pollak, and H. Huynh
Inhibition of Insulin-like Growth Factor Signaling Pathways in Mammary Gland by Pure Antiestrogen ICI 182,780
Clin. Cancer Res., August 1, 2001; 7(8): 2545 - 2554.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Gebre-Medhin, L.-G. Kindblom, H. Wennbo, J. Tornell, and J. M. Meis-Kindblom
Growth Hormone Receptor Is Expressed in Human Breast Cancer
Am. J. Pathol., April 1, 2001; 158(4): 1217 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. K. Kaulsay, T. Zhu, W. F. Bennett, K.-O. Lee, and P. E. Lobie
The Effects of Autocrine Human Growth Hormone (hGH) on Human Mammary Carcinoma Cell Behavior Are Mediated via the hGH Receptor
Endocrinology, February 1, 2001; 142(2): 767 - 777.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
P. E. Blackshear
Genetically Engineered Rodent Models of Mammary Gland Carcinogenesis: An Overview
Toxicol Pathol, January 1, 2001; 29(1): 105 - 116.
[Abstract] [PDF]

Home page
 EndocrinologyHome page
W. S. Cohick, B. Wang, P. Verma, and Y. R. Boisclair
Insulin-Like Growth Factor I (IGF-I) and Cyclic Adenosine 3',5'-Monophosphate Regulate IGF-Binding Protein-3 Gene Expression by Transcriptional and Posttranscriptional Mechanisms in Mammary Epithelial Cells
Endocrinology, December 1, 2000; 141(12): 4583 - 4591.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. L. Woodward, J. Xie, J. L. Fendrick, and S. Z. Haslam
Proliferation of Mouse Mammary Epithelial Cells in Vitro: Interactions among Epidermal Growth Factor, Insulin-Like Growth Factor I, Ovarian Hormones, and Extracellular Matrix Proteins
Endocrinology, October 1, 2000; 141(10): 3578 - 3586.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society